Table 3 Adverse events during 12-week period of the study
Adverse reactions | AS group (N = 68) | |
|---|---|---|
Kunxian, n = 35 | Placebo, n = 33 | |
Elevated AST/ALT | 3 | 2 |
Dysmenorrhea | 1 | 0 |
Gastrointestinal discomfort | 4 | 1 |
Leukopenia/thrombocytopenia | 0 | 0 |
Urinary tract infection (urinary frequency, hematuria) | 0 | 0 |
Dry throat | 0 | 0 |
Drug allergy | 0 | 0 |
Total | 8a | 3 |